OCS Lung
DeviceThe TransMedics Organ Care System (OCS) Lung is an FDA approved portable extracorporeal lung perfusion and monitoring system.
NCT Number: NCT06513091
The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.
Interested in participating?
Request InfoAll sexes
Observational
St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
All lung transplant recipients
The TransMedics Organ Care System (OCS) Lung is an FDA approved portable extracorporeal lung perfusion and monitoring system.
Time frame: 1-year post-transplant
Recipients' one-year patient and graft survival rates
Contact information is provided by the study sponsor or research team.
TransMedics
Industry
US National OCS Lung Thoracic Organ Perfusion (TOP) Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07516379
Behavior, End Stage Lung Disease
Bethesda, Maryland, United States
View Trial DetailsNCT03886961
Deglutition Disorders, Digestive System Diseases
Gainesville, Florida, United States
View Trial DetailsNCT06033196
Lung Transplant
Phoenix, Arizona, United States
View Trial DetailsNCT06476132
Acute Lung Injury, Bronchial Diseases
Los Angeles, California, United States
View Trial Details